TWD 70.8
(0.28%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 5.45 Million TWD | -11.71% |
2022 | 6.17 Million TWD | 1.06% |
2021 | 6.1 Million TWD | 52.19% |
2020 | 4.01 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 5.17 Million TWD | 37.78% |
2024 Q1 | 4.98 Million TWD | -8.6% |
2023 Q2 | 5.17 Million TWD | 0.0% |
2023 FY | 5.45 Million TWD | -11.71% |
2023 Q4 | 5.45 Million TWD | -27.36% |
2023 Q3 | 7.5 Million TWD | 44.95% |
2023 Q1 | - TWD | -100.0% |
2022 FY | 6.17 Million TWD | 1.06% |
2022 Q4 | 6.17 Million TWD | 0.0% |
2021 FY | 6.1 Million TWD | 52.19% |
2020 FY | 4.01 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Apex Biotechnology Corp. | 747.71 Million TWD | 99.271% |
Sinphar Pharmaceutical Co.,Ltd. | 839.19 Million TWD | 99.35% |
Panion & Bf Biotech Inc. | 538.09 Million TWD | 98.987% |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. | 1.21 Billion TWD | 99.55% |
GenMont Biotech Incorporation | 88.11 Million TWD | 93.814% |
Abnova (Taiwan) Corporation | 408.3 Million TWD | 98.665% |
Adimmune Corporation | 526.4 Million TWD | 98.964% |
Tanvex BioPharma, Inc. | 108.28 Million TWD | 94.966% |
Polaris Group | 36.35 Million TWD | 85.006% |
Energenesis Biomedical CO.,LTD. | 733 Thousand TWD | -643.656% |
PELL Bio-Med Technology Co. Ltd. | 3.76 Million TWD | -44.858% |